Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clofarabine Containing Conditioning Regimen for Allo-SCT in AML/ALL Patients: A Survey From the Acute Leukemia Working Party of EBMT

Patrice Chevallier, Myriam Labopin, MD, MS, Stefanie Buchholz, Arnold Ganser, MD, Fabio Ciceri, MD, Bruno Lioure, Christoph Faul, MD, Gaelle Guillerm, Juergen Finke, MD, Anne Huynh, MD, Joerg Schubert, MD, Hans Jochem Kolb, MD, Emmanuelle Polge, Arnon Nagler, M.D., Mohamad Mohty, MD, PhD

Blood (2011) 118 (21): 3004.

https://doi.org/10.1182/blood.V118.21.3004.3004

Published: 2011

Journal Articles

Adaptor Protein LNK Binds to and Is Phosphorylated by JAK3 and May Serve as a Scaffold for JAK3 Autophosphorylation In the Absence of An Appropriate Cytokine Receptor

Maya koren-Michowitz, MD, Sigal Gery, PhD, Daniel Nowak, MD, Arnon Nagler, M.D., Aiko Matsubara, MS, Takayuki Tabayashi, MD, PhD, Seishi Ogawa, MD, PhD, H. Phillip Koeffler, MD

Blood (2010) 116 (21): 2785.

https://doi.org/10.1182/blood.V116.21.2785.2785

Published: 2010

Journal Articles

Multiple Myeloma and Microenvironment Formation: The Role of CXCR4/CXCL12 Chemokine Pathway

Katia Beider, Avichai Shimoni, Odit Gutwein, Merav Leiba, Elena Ribakovsky, Nira Bloom, Amnon Peled, Arnon Nagler, M.D.

Blood (2010) 116 (21): 2962.

https://doi.org/10.1182/blood.V116.21.2962.2962

Published: 2010

Journal Articles

BKT140 Is a Novel CXCR4 Antagonist with Stem Cell Mobilization and Antimyeloma Effects: An Open-Label First Human Trial In Patients with Multiple Myeloma Undergoing Stem Cell Mobilization for Autologous Transplantation

Arnon Nagler, M.D., Avichai Shimoni, Irit Avivi, Jacob M. Rowe, Katia Beider, Izhar Hardan, Michal Abraham, Hanna Wald, Eithan Galun, Howard Laurence Shaw, Orly Eizenberg, Amnon Peled

Blood (2010) 116 (21): 2260.

https://doi.org/10.1182/blood.V116.21.2260.2260

Published: 2010

Journal Articles

A Multi-Center Prospective Randomized Study Comparing Ibritumomab Tiuxetan (Zevalin) and High-Dose BEAM Chemotherapy (Z-BEAM) Vs. BEAM Alone as the Conditioning Regimen Prior to Autologous Stem-Cell Transplantation In Patients with Aggressive Lymphoma; Possible Advantage for Z-BEAM In Low-Risk Patients

Avichai Shimoni, MD, Irit Avivi, MD, Jacob M. Rowe, Moshe Yeshurun, MD, Itai Levi, MD, Reuven Or, MD, Paulina Patachenko, MD, Abraham Avigdor, MD, Tzila Zwas, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 686.

https://doi.org/10.1182/blood.V116.21.686.686

Published: 2010

Journal Articles

Halofuginone Induces Post-Transcriptional Down-Regulation of Cyclin D1, Cell Cycle Arrest and Apoptosis In Mantle Cell Lymphoma Cells through Activation of Integrated Stress Response Pathways

Rodrigo Proto-Siqueira, PhD, Melina G. Santos, Valdemir M. Carvalho, PhD, Yumi H. Maekawa, MSc, Leonardo A. Testagrossa, MD, Zelia R. Andrade, MSc, José Salvador Oliveira, Maria de Lourdes L. F. Chauffaille, MD, PhD, Marco A. Zago, MD, PhD, Arnon Nagler, M.D., Adrian Wiestner, Edgar Gil Rizzatti, MD, PhD

Blood (2010) 116 (21): 773.

https://doi.org/10.1182/blood.V116.21.773.773

Published: 2010

Journal Articles

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Irit Avivi, MD, Carmen Canals, Jian Jian Luan, Gerald. G. Wulf, Arnon Nagler, M.D., Agnes Buyzin, Eefke J. Petersen, MD, PhD, Jean-Pierre Jouet, MD, Donald Milligan, MD, FRCP, FRCPath, Anton Schattenberg, MD, Dietger W Niederwieser, MD, Kirsty Thomson, Didier Blaise, MD, Michel Attal, Gerhard Held, MD, Peter Dreger, MD, PhD, Anna Sureda, MD, PhD

Blood (2010) 116 (21): 363.

https://doi.org/10.1182/blood.V116.21.363.363

Published: 2010

Journal Articles

Modulation of Multiple Myeloma Apoptosis and Adhesion by Seliciclib, A Selective Inhibitor of Cyclin Dependent Kinase (CDK)

Liat Josefsberg Ben-Yehuda, Michal Samookh, Arnon Nagler, M.D.

Blood (2010) 116 (21): 3971.

https://doi.org/10.1182/blood.V116.21.3971.3971

Published: 2010

Journal Articles

Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model

Assaf Lask, MSc, Eran Ophir, MSc, Noga Or-Geva, BSc, Adva Cohen, MSc, Ran Afik, MSc, Yaki Eidelstein, MSc, Robert Negrin, MD, Arnon Nagler, M.D., Alain Berrebi, MD, David Hagin, MD, Yair Reisner, PhD

Blood (2010) 116 (21): 424.

https://doi.org/10.1182/blood.V116.21.424.424

Published: 2010

Journal Articles

Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT.

Mohamad Mohty, Myriam Labopin, MD, Jurgen Finke, MD, Christoph Schmid, H.J. Kolb, M.D., Andrea Bacigalupo, MD, Didier Blaise, MD, Jérôme Cornillon, Noel Milpied, MD, J.R. Cabrera-Marin, M.D., Fabio Ciceri, M.D., Vanderson Rocha, Arnon Nagler, M.D.

Blood (2010) 116 (21): 3447.

https://doi.org/10.1182/blood.V116.21.3447.3447

Published: 2010

Journal Articles

The Impact of Center Experience on Results of Reduced Intensity – Allogeneic Hematopoietic Stem Cell Transplantation. A Survey From the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Sebastian Giebel, Myriam Labopin, MD, Mohamad Mohty, Didier Blaise, MD, Charles Craddock, Arnon Nagler, M.D., Francesco Frassoni, MD, Maria Sadus-Wojciechowska, Vanderson Rocha

Blood (2010) 116 (21): 3517.

https://doi.org/10.1182/blood.V116.21.3517.3517

Published: 2010

Journal Articles

Fludarabine and Treosulfan Conditioning for Allogeneic Stem-Cell Transplantation; a Dose- Intense Regimen with Limited Toxicity.

Avichai Shimoni, MD, Avital Rand, RN, BSN, Noga Shem-Tov, Izhar Hardan, Yulia Volchek, MD, Ronit Yerushalmi, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 3473.

https://doi.org/10.1182/blood.V116.21.3473.3473

Published: 2010

Journal Articles

Combining the Ras Inhibitor Salirasib and Proteasome Inhibitors: A Potential Treatment for Multiple Myeloma

Shira Yaari-Stark, Yael Nevo-Caspi, Jasmine Jacob-Hircsh, Gideon Rechavi, MD, PhD, Arnon Nagler, M.D., Yoel Kloog

Blood (2010) 116 (21): 1810.

https://doi.org/10.1182/blood.V116.21.1810.1810

Published: 2010

Journal Articles

Analysis of the Crosstalk Between TGF-β–VEGF-Angiogenesis in an In Vivo Model of Acute Promyelocytic Leukemia

Patricia Aparecida Assis, Lorena Lobo Figueiredo Pontes, Antonio Roberto Lucena Araújo, Aglair Bergamo Garcia, Roberto P. Falcao, MD, PhD, Fernando Chahud, Arnon Nagler, M.D., Eduardo M. Rego, MD, PhD

Blood (2010) 116 (21): 1845.

https://doi.org/10.1182/blood.V116.21.1845.1845

Published: 2010

Journal Articles

Attempt to Discontinue Imatinib Following Interferon Alfa Pre-Treatment In Chronic Phase CML Patients Achieving Stable Complete Cytogentic Responses (CCyR)

Izhar Hardan, Yulia Volchek, MD, Tali Tohami, MD, PhD, Ninette Amariglio, Luba Trakhtenbrot, Maya Koren-Michowitz, Arnon Nagler, M.D.

Blood (2010) 116 (21): 4898.

https://doi.org/10.1182/blood.V116.21.4898.4898

Published: 2010

Journal Articles

Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement

Lisa Billecke, PhD, Eva Maria Murga Penas, PhD, Annette May, PhD, Monika Engelhardt, Arnon Nagler, M.D., Merav Leiba, PhD, Nicolaus Kröger, PhD, Jozef Zustin, PhD, Andreas Marx, PhD, Jakob Matschke, Markus Tiemann, MD, Eray Gökkurt, Carsten Bokemeyer, MD, Georgia Schilling, PhD

Blood (2010) 116 (21): 4993.

https://doi.org/10.1182/blood.V116.21.4993.4993

Published: 2010

Journal Articles

Donor Lymphocyte Infusions and Second Transplantation as Salvage Treatment for Relapsed Myelofibrosis After Reduced-Intensity allografting.

Nicolaus Kröger, Evgeny Klyuchnikov, MD, Daniel Wolff, Martin Bornhäuser, Guido Kobbe, MD, Arnon Nagler, M.D., Avichai Shimoni, Christian Koenecke, Christine Wolschke, MD, Ulrike Bacher, Axel R. Zander, MD

Blood (2010) 116 (21): 1300.

https://doi.org/10.1182/blood.V116.21.1300.1300

Published: 2010

Journal Articles

Cyclosporine and Methotrexate Compared with Cyclosporine and Mycophenolate Mofetil as GVHD Prevention Regimens In Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation

Avichai Shimoni, MD, Avital Rand, RN, BSN, Noga Shem-Tov, MD, Izhar Hardan, MD, Yulia Volchek, MD, Ronit Yerushalmi, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 2314.

https://doi.org/10.1182/blood.V116.21.2314.2314

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib

Michael Schleuning, MD, Marijke Scholten, Anja van Biezen, Arnon Nagler, M.D., Jane F. Apperley, MD, Mauricette Michallet, MD, Andrew Grigg, MD, Richard T. Silver, MD, Armin Leitner, MD, Alois Gratwohl, MD, Marja Ekblom, MD, PhD, H. Jean Khoury, MD, Theo de Witte, MD, Eduardo Olavarría, MD

Blood (2010) 116 (21): 2348.

https://doi.org/10.1182/blood.V116.21.2348.2348

Published: 2010

Journal Articles

Older Patients with Normal Cytogenetics AML Have a Higher Rate of Genomic Changes Compared to Young Patients as Determined by SNP Chip Analysis

Maya koren-Michowitz, MD, Carsten Müller-Tidow, MD, Aiko Matsubara, MS, Stefanie Göllner, PhD, Wolfgang E. Berdel, Arnon Nagler, M.D., Seishi Ogawa, MD, PhD, H. Phillip Koeffler, MD

Blood (2010) 116 (21): 2479.

https://doi.org/10.1182/blood.V116.21.2479.2479

Published: 2010

NARROW

Clofarabine Containing Conditioning Regimen for Allo-SCT in AML/ALL Patients: A Survey From the Acute Leukemia Working Party of EBMT

Adaptor Protein LNK Binds to and Is Phosphorylated by JAK3 and May Serve as a Scaffold for JAK3 Autophosphorylation In the Absence of An Appropriate Cytokine Receptor

Multiple Myeloma and Microenvironment Formation: The Role of CXCR4/CXCL12 Chemokine Pathway

BKT140 Is a Novel CXCR4 Antagonist with Stem Cell Mobilization and Antimyeloma Effects: An Open-Label First Human Trial In Patients with Multiple Myeloma Undergoing Stem Cell Mobilization for Autologous Transplantation

Halofuginone Induces Post-Transcriptional Down-Regulation of Cyclin D1, Cell Cycle Arrest and Apoptosis In Mantle Cell Lymphoma Cells through Activation of Integrated Stress Response Pathways

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Modulation of Multiple Myeloma Apoptosis and Adhesion by Seliciclib, A Selective Inhibitor of Cyclin Dependent Kinase (CDK)

Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model

Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT.

The Impact of Center Experience on Results of Reduced Intensity – Allogeneic Hematopoietic Stem Cell Transplantation. A Survey From the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Fludarabine and Treosulfan Conditioning for Allogeneic Stem-Cell Transplantation; a Dose- Intense Regimen with Limited Toxicity.

Combining the Ras Inhibitor Salirasib and Proteasome Inhibitors: A Potential Treatment for Multiple Myeloma

Analysis of the Crosstalk Between TGF-β–VEGF-Angiogenesis in an In Vivo Model of Acute Promyelocytic Leukemia

Attempt to Discontinue Imatinib Following Interferon Alfa Pre-Treatment In Chronic Phase CML Patients Achieving Stable Complete Cytogentic Responses (CCyR)

Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement

Donor Lymphocyte Infusions and Second Transplantation as Salvage Treatment for Relapsed Myelofibrosis After Reduced-Intensity allografting.

Cyclosporine and Methotrexate Compared with Cyclosporine and Mycophenolate Mofetil as GVHD Prevention Regimens In Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation

Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib

Older Patients with Normal Cytogenetics AML Have a Higher Rate of Genomic Changes Compared to Young Patients as Determined by SNP Chip Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only